▼ 7.20% QoQ
▲ 1.68% QoQ
▼ 149 bps QoQ
▼ 192 bps QoQ
The results present a mixed picture for the S&P Global-backed rating agency, with robust topline expansion offset by margin compression and rising employee costs. Whilst revenue growth accelerated to an impressive 27.56% year-on-year, operating margins contracted 149 basis points sequentially to 28.63%, marking the lowest level in the past four quarters. The company's ability to convert revenue growth into bottom-line expansion remains under scrutiny as employee costs surged to ₹576.94 crores, representing 53.66% of total revenue.
| Quarter | Jun'26 | Mar'26 | Dec'25 | Sep'25 | Jun'25 | Mar'25 | Dec'24 |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,075.39 | 1,057.66 | 1,081.57 | 911.24 | 843.02 | 813.18 | 912.91 |
| QoQ Growth | +1.68% | -2.21% | +18.69% | +8.09% | +3.67% | -10.92% | — |
| Net Profit (₹ Cr) | 216.46 | 233.26 | 241.50 | 193.10 | 171.57 | 159.84 | 224.69 |
| QoQ Growth | -7.20% | -3.41% | +25.06% | +12.55% | +7.34% | -28.86% | — |
| Operating Margin | 28.63% | 30.12% | 31.40% | 28.89% | 28.32% | 28.53% | 31.45% |
| PAT Margin | 20.13% | 22.05% | 22.33% | 21.19% | 20.35% | 19.66% | 24.61% |
Financial Performance: Growth Trajectory Intact, Profitability Under Pressure
CRISIL's Q1 FY27 revenue performance demonstrated remarkable resilience, with net sales reaching ₹1,075.39 crores, marking a sequential increase of 1.68% over Q4 FY26's ₹1,057.66 crores and a robust year-on-year expansion of 27.56% from ₹843.02 crores. This represents the second-highest quarterly revenue in the company's recent history, trailing only the December 2025 quarter's ₹1,081.57 crores. The consistent topline momentum underscores CRISIL's strong market positioning in credit ratings and research analytics services.
However, the margin narrative tells a more concerning story. Operating profit excluding other income declined to ₹307.87 crores in Q1 FY27 from ₹318.57 crores in the previous quarter, translating to an operating margin of 28.63%—a contraction of 149 basis points quarter-on-quarter. The year-on-year comparison shows marginal improvement of 31 basis points from 28.32%, but this masks the sequential deterioration trend observed over the past two quarters. The company's gross profit margin similarly compressed to 29.97% from 32.88% in Q4 FY26, whilst PAT margin slipped to 20.13% from 22.05%.
▲ 27.56% YoY
▲ 26.16% YoY
▲ 31 bps YoY
▼ 22 bps YoY
The principal culprit behind margin erosion lies in employee costs, which surged to ₹576.94 crores in Q1 FY27 from ₹556.14 crores in the preceding quarter—an increase of 3.74% quarter-on-quarter. On a year-on-year basis, employee expenses jumped 24.67% from ₹462.77 crores, outpacing revenue growth and suggesting potential wage inflation or headcount expansion to support business growth. Employee costs now constitute 53.66% of revenue, up from 52.59% in Q4 FY26 and 54.90% a year ago.
Other income declined sharply to ₹21.14 crores from ₹36.01 crores in Q4 FY26, representing a 41.29% sequential drop. This contributed to the overall profit before tax declining 9.25% quarter-on-quarter to ₹279.84 crores, despite the healthy topline growth. The effective tax rate moderated to 22.65% from 24.36% in the previous quarter, providing some cushion to net profit, which ultimately settled at ₹216.46 crores.
Operational Excellence: Capital Efficiency Remains World-Class
Despite near-term margin pressures, CRISIL continues to demonstrate exceptional capital efficiency metrics that place it amongst India's highest-quality businesses. The company's return on capital employed (ROCE) stood at an impressive 40.73% as of the latest reporting period, whilst the five-year average ROCE remains at an outstanding 52.83%. This reflects CRISIL's asset-light business model and strong pricing power in the credit rating and analytics segments.
Return on equity (ROE) of 25.25% in the latest period, with a five-year average of 28.60%, underscores the company's ability to generate superior returns for shareholders. These profitability metrics significantly exceed the cost of capital and compare favourably with global peers in the rating agency space. The company's balance sheet remains fortress-like, with zero long-term debt and shareholder funds of ₹3,033.44 crores as of December 2025, up from ₹2,564.82 crores a year earlier.
Balance Sheet Strength: A Net Cash Fortress
CRISIL operates with a debt-free balance sheet, boasting net cash of approximately ₹814.03 crores (cash and investments of ₹814.03 crores with zero debt). The company's average net debt-to-equity ratio of -0.24 indicates it holds more cash than debt, providing significant financial flexibility for growth investments, acquisitions, or enhanced shareholder returns. Current assets of ₹2,269.65 crores comfortably exceed current liabilities of ₹1,206.30 crores, ensuring robust liquidity.
The company's sales-to-capital-employed ratio of 1.34x demonstrates efficient asset utilisation, whilst interest coverage remains exceptional at 100.00x (given minimal interest costs of ₹6.70 crores in Q1 FY27). Fixed assets increased substantially to ₹1,139.49 crores in December 2025 from ₹693.01 crores a year earlier, likely reflecting investments in technology infrastructure and office facilities to support business expansion.
Cash flow generation remains healthy, with operating cash flow of ₹755.00 crores in December 2025, though marginally lower than the previous year's ₹765.00 crores. The company deployed ₹267.00 crores in investing activities and returned ₹469.00 crores to shareholders through dividends and buybacks in financing activities, demonstrating disciplined capital allocation.
The Employee Cost Challenge: Balancing Growth and Profitability
The most pressing operational concern for CRISIL centres on the trajectory of employee costs, which have grown at a compounded annual rate exceeding revenue growth over recent quarters. In Q1 FY27, employee expenses of ₹576.94 crores represented 53.66% of revenue, creating structural pressure on operating leverage. This ratio has remained stubbornly elevated across the past seven quarters, oscillating between 52% and 57%.
The knowledge-intensive nature of CRISIL's business—spanning credit rating analysis, risk assessment, and research services—necessitates significant investment in skilled talent. However, the current employee cost trajectory raises questions about operating efficiency and scalability. The company faces a delicate balancing act: maintaining talent quality and competitiveness in a tight labour market whilst preserving the margin profile that has historically characterised its operations.
Margin Watch: Operating Leverage Under Scrutiny
CRISIL's operating margin (excluding other income) has declined from a peak of 31.45% in December 2024 to 28.63% in June 2026, representing a compression of 282 basis points. Whilst the company maintains healthy absolute profitability, the trend warrants close monitoring. Management's ability to rationalise costs, improve productivity through technology, and leverage scale will be critical to restoring margin expansion in coming quarters. The five-year average operating margin of 27.9% provides a benchmark, suggesting current levels remain within historical ranges but below recent peaks.
Industry Context: Capital Markets Sector Faces Headwinds
CRISIL operates within India's capital markets sector, which has experienced significant volatility over the past year. The broader sector has declined 21.24% over the past 12 months, with CRISIL slightly underperforming at -22.71%. This reflects challenging market conditions characterised by reduced capital markets activity, lower deal volumes, and muted investor sentiment affecting financial services companies.
As the largest company in the capital markets sector with a market capitalisation of ₹32,700.09 crores, CRISIL holds a dominant position. However, its fortunes remain partly tied to the overall health of India's credit markets, corporate bond issuances, and structured finance activity—all of which have moderated from peak levels. The company's diversification into global research and analytics provides some insulation from purely domestic capital markets cycles.
The regulatory environment remains supportive, with the Securities and Exchange Board of India (SEBI) maintaining stringent credit rating requirements for debt securities. This creates a structural demand floor for CRISIL's core rating services. However, increased competition from newer rating agencies and pricing pressures in certain segments present ongoing challenges to market share and pricing power.
| Company | P/E (TTM) | P/BV | ROE (%) | Dividend Yield |
|---|---|---|---|---|
| CRISIL | 37.54x | 10.39x | 28.60% | 1.44% |
| Motilal Oswal Financial | 31.07x | 4.51x | 20.55% | 0.62% |
| 360 ONE | 35.92x | 4.61x | 18.22% | 1.07% |
| Anand Rathi Wealth | 74.63x | 34.76x | 38.69% | 0.31% |
| Nuvama Wealth | 33.16x | 8.38x | 26.76% | 1.47% |
| Aditya Birla AMC | 30.87x | 7.46x | 25.62% | 2.30% |
Peer Comparison: Premium Valuation Reflects Quality, But Stretched
CRISIL commands a premium valuation relative to capital markets peers, trading at 37.54x trailing twelve-month earnings—above the sector average of approximately 34x. This premium reflects the company's market leadership position, superior profitability metrics, and the defensive characteristics of its rating business. However, the valuation multiple has expanded from historical averages, raising questions about the risk-reward equation at current levels.
The company's price-to-book value of 10.39x significantly exceeds most peers except Anand Rathi Wealth (34.76x), though it trails the peer group average when excluding outliers. This elevated P/BV multiple is justified by CRISIL's exceptional return on equity of 28.60%, which surpasses most competitors except Anand Rathi Wealth's 38.69%. The ROE-to-P/BV relationship suggests reasonable value creation, though the margin of safety appears limited.
CRISIL's dividend yield of 1.44% sits in the middle of the peer range, with the company maintaining a payout ratio of 57.26%. This reflects a balanced approach to capital allocation, returning substantial cash to shareholders whilst retaining sufficient capital for growth investments. The latest dividend of ₹8.97 per share went ex-dividend in April 2026.
Valuation Analysis: Premium Pricing Leaves Little Room for Error
At the current market price of ₹4,471.50, CRISIL trades at 37.54x trailing earnings, representing a significant premium to its historical average and the broader market. The company's enterprise value-to-EBITDA multiple of 26.55x and EV-to-EBIT of 30.14x further underscore the rich valuation. Whilst these multiples reflect the high-quality nature of CRISIL's franchise, they also embed optimistic expectations for sustained growth and margin expansion.
The PEG ratio of 1.99x suggests the stock is trading above its growth rate, with five-year sales growth of 13.70% and EBIT growth of 21.37% not fully justifying the valuation premium. In a normalised scenario assuming 15-18% earnings growth and a target multiple of 30-32x earnings, fair value would approximate ₹3,800-4,100, implying 10-15% downside from current levels.
The stock's classification as "Very Expensive" in valuation assessments since late 2022 reflects this stretched positioning. Historical patterns show CRISIL has oscillated between "Expensive" and "Very Expensive" bands, rarely trading at "Fair" or "Cheap" valuations given its quality characteristics. However, the current margin pressures and moderating growth trajectory suggest limited catalysts for multiple expansion from here.
Shareholding Pattern: Stable Promoter Base, Marginal Institutional Shifts
CRISIL's shareholding structure remains remarkably stable, with promoter holding locked at 66.64% across the past five quarters. The promoter group, comprising S&P India LLC (42.68%), S&P Asian Holding Pte. Ltd. (15.76%), and S&P International LLC (8.20%), demonstrates unwavering commitment to the Indian subsidiary. This majority ownership by S&P Global provides strategic stability and access to global best practices, though it also limits free float and liquidity.
Foreign institutional investor (FII) holdings declined marginally to 7.18% in March 2026 from 7.67% in December 2025, continuing a gradual reduction trend from 8.07% in June 2025. This 89 basis points reduction over three quarters suggests some foreign investors have trimmed positions, possibly on valuation concerns or sector rotation. The presence of 206 FIIs indicates broad-based international interest despite the recent reduction.
| Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 66.64% | 66.64% | 66.64% | 66.64% | 0.00% |
| FII | 7.18% | 7.67% | 7.82% | 8.07% | -0.49% |
| Mutual Funds | 6.95% | 6.55% | 6.85% | 6.63% | +0.40% |
| Insurance | 5.28% | 5.14% | 4.80% | 4.98% | +0.14% |
| Other DII | 0.38% | 0.41% | 0.53% | 0.45% | -0.03% |
| Non-Institutional | 13.57% | 13.59% | 13.37% | 13.22% | -0.02% |
Domestic mutual fund holdings increased to 6.95% in March 2026 from 6.55% in December 2025, representing a 40 basis points sequential increase. With 99 mutual funds holding positions, CRISIL remains a favoured holding amongst domestic institutional investors who value its quality characteristics and market leadership. Insurance company holdings similarly ticked up to 5.28% from 5.14%, suggesting continued confidence from long-term domestic institutional investors.
The non-institutional category, comprising retail and high-net-worth investors, remained stable at 13.57%. The absence of promoter pledging and the strong institutional ownership base (approximately 20% combined domestic and foreign institutions) provide governance comfort and suggest long-term investor conviction despite near-term performance concerns.
Stock Performance: Significant Underperformance Marks the Past Year
CRISIL's stock performance over the past year has been disappointing, with shares declining 22.71% compared to the Sensex's 6.47% fall, resulting in negative alpha of 16.24 percentage points. This underperformance reflects both company-specific concerns around margin trajectory and broader sector weakness in capital markets stocks. The stock trades 24.21% below its 52-week high of ₹5,899.50 but remains 21.21% above the 52-week low of ₹3,689.00.
Recent momentum has turned positive, with the stock gaining 6.23% over the past week and 5.76% over the past month, outperforming the Sensex significantly during these shorter timeframes. Year-to-date returns of 3.38% compare favourably to the Sensex's 9.80% decline, suggesting some recovery from earlier weakness. The stock trades above all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating improving technical momentum.
| Period | CRISIL Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +6.23% | -0.41% | +6.64% |
| 1 Month | +5.76% | -0.29% | +6.05% |
| 3 Months | +2.83% | -2.10% | +4.93% |
| 6 Months | -1.47% | -6.61% | +5.14% |
| YTD | +3.38% | -9.80% | +13.18% |
| 1 Year | -22.71% | -6.47% | -16.24% |
| 3 Years | +14.79% | +15.27% | -0.48% |
| 5 Years | +42.75% | +45.48% | -2.73% |
The stock's beta of 1.20 indicates higher volatility than the broader market, with 27.38% annualised volatility compared to the Sensex's 13.53%. This elevated volatility, combined with negative one-year returns, results in a risk-adjusted return of -0.83, placing CRISIL in the "Medium Risk Low Return" category—an unfavourable combination for investors. The negative Sharpe ratio underscores the poor risk-reward profile over the past year.
Technical indicators present a mixed picture. The overall trend classification of "Mildly Bearish" (changed from "Bearish" on July 10, 2026) suggests improving momentum but continued caution. Weekly MACD shows mildly bullish signals, whilst monthly MACD remains bearish. Bollinger Bands indicate bullish positioning on weekly charts but mildly bearish on monthly timeframes. Delivery volumes have surged recently, with one-day delivery at 64.18% of total volume—significantly above the five-day average of 50.10%—suggesting genuine buying interest rather than speculative trading.
Investment Thesis: Quality Company, Challenging Entry Point
CRISIL's investment thesis rests on four pillars: market leadership in credit ratings, asset-light business model with exceptional capital efficiency, fortress balance sheet with zero debt, and strong parentage through S&P Global. The company's quality grade of "Good" reflects consistent financial performance, with five-year sales CAGR of 13.70% and EBIT growth of 21.37%. Return ratios remain world-class, with average ROCE of 52.83% and ROE of 28.60%.
However, multiple headwinds cloud the near-term outlook. The financial trend, whilst classified as "Positive" for Q1 FY27, shows margin compression that could persist if employee cost pressures continue. Technical indicators remain "Mildly Bearish," suggesting limited momentum. Most critically, valuation remains "Very Expensive" at 37.54x earnings, leaving minimal margin of safety.
Key Strengths & Risk Factors
✅ KEY STRENGTHS
- Market Leadership: Dominant position in India's credit rating industry with established brand equity and regulatory moat
- Exceptional Capital Efficiency: ROCE of 52.83% (5-year average) and ROE of 28.60% demonstrate superior profitability and asset-light model
- Fortress Balance Sheet: Zero debt with net cash of ₹814 crores provides financial flexibility and resilience
- S&P Global Parentage: Strategic backing from global leader provides access to technology, methodologies, and international best practices
- Consistent Revenue Growth: 27.56% YoY revenue growth in Q1 FY27 demonstrates strong demand for services
- Diversified Revenue Streams: Presence across ratings, research, and analytics reduces dependence on single business line
- Strong Dividend Track Record: Consistent dividend payer with 57.26% payout ratio balances returns with reinvestment
⚠️ KEY CONCERNS
- Margin Compression: Operating margin declined 149 bps QoQ to 28.63%, lowest in four quarters, raising profitability concerns
- Rising Employee Costs: Employee expenses at 53.66% of revenue outpacing topline growth, limiting operating leverage
- Stretched Valuation: Trading at 37.54x earnings with "Very Expensive" classification leaves minimal margin of safety
- Sector Headwinds: Capital markets sector down 21.24% in past year reflects challenging industry environment
- Limited Free Float: 66.64% promoter holding restricts liquidity and limits institutional participation potential
- Sequential Profit Decline: Net profit down 7.20% QoQ despite revenue growth indicates margin pressure impact
- FII Selling: Foreign institutional holding declined from 8.07% to 7.18% over three quarters suggests reduced conviction
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS
- Stabilisation or improvement in operating margins above 30% would restore confidence in business model scalability
- Revival in capital markets activity and bond issuances could drive revenue acceleration
- Successful cost optimisation initiatives to moderate employee cost-to-revenue ratio below 52%
- Market share gains in ratings or research segments through new client wins
- Valuation correction to 30-32x earnings would improve risk-reward equation for entry
RED FLAGS
- Further margin compression below 28% would signal structural profitability challenges
- Continued FII selling or reduction in domestic institutional holdings below 12%
- Revenue growth deceleration below 15% YoY indicating market share loss or sector weakness
- Employee cost ratio exceeding 55% of revenue on sustained basis
- Breakdown below ₹4,000 levels would trigger technical selling and test 52-week lows
The Verdict: Quality at a Price – Wait for Better Entry
Score: 42/100
For Fresh Investors: Avoid initiating positions at current levels. Whilst CRISIL remains a high-quality franchise with strong fundamentals, the combination of stretched valuation (37.54x earnings), margin pressures, and mildly bearish technical trend creates an unfavourable risk-reward equation. Consider building positions only on significant corrections towards ₹3,800-4,000 levels, representing 10-15% downside from current prices.
For Existing Holders: Consider booking partial profits, particularly if holding gains exceed 20%. The stock's 22.71% decline over the past year has eroded value, but recent recovery presents an opportunity to reduce exposure. Retain core holdings given the company's quality characteristics, but trim positions to book gains and redeploy capital to better risk-reward opportunities. Maintain strict stop-loss discipline.
Fair Value Estimate: ₹3,900 (12.78% downside from current price of ₹4,471.50)
Rationale: Despite CRISIL's undeniable quality—fortress balance sheet, market leadership, and exceptional return ratios—the investment case is undermined by premium valuation with limited margin of safety, sequential margin compression requiring management attention, and sector headwinds affecting capital markets companies. The proprietary Mojo score of 42/100 and "SELL" rating reflect these concerns. Quality businesses deserve premium valuations, but not at any price. Patience will likely be rewarded with better entry opportunities.
Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
